Trial · NCT00747123
Results by group76
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 76
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Treatment Emergent Adverse Events (TEAEs) | Placebo | 4 | Participants | ||
| Number of Participants With Treatment Emergent Adverse Events (TEAEs) | 0.1 mg/kg ACE 011 | 7 | Participants | ||
| Number of Participants With Treatment Emergent Adverse Events (TEAEs) | 0.3 mg/kg ACE 011 | 7 | Participants | ||
| Number of Participants With Treatment Emergent Adverse Events (TEAEs) | 0.5 mg/kg ACE 011 | 8 | Participants | ||
| Number of Participants With Treatment Emergent Adverse Events (TEAEs) Related to Study Drug | Placebo | 0 | Participants | ||
| Number of Participants With Treatment Emergent Adverse Events (TEAEs) Related to Study Drug | 0.1 mg/kg ACE 011 | 1 | Participants | ||
| Number of Participants With Treatment Emergent Adverse Events (TEAEs) Related to Study Drug | 0.3 mg/kg ACE 011 | 0 | Participants | ||
| Number of Participants With Treatment Emergent Adverse Events (TEAEs) Related to Study Drug | 0.5 mg/kg ACE 011 | 1 | Participants | ||
| Number of Participants With Serious Adverse Events (SAEs) | Placebo | 0 | Participants | ||
| Number of Participants With Serious Adverse Events (SAEs) | 0.1 mg/kg ACE 011 | 1 | Participants | ||
| Number of Participants With Serious Adverse Events (SAEs) | 0.3 mg/kg ACE 011 | 0 | Participants | ||
| Number of Participants With Serious Adverse Events (SAEs) | 0.5 mg/kg ACE 011 | 3 | Participants | ||
| Change From Baseline in Hemoglobin | Placebo | Day 8 | 0.47 | Standard Deviation 0.288 | g/dL |
| Change From Baseline in Hemoglobin | 0.1 mg/kg ACE 011 | Day 8 | 0.89 | Standard Deviation 1.254 | g/dL |
| Change From Baseline in Hemoglobin | 0.3 mg/kg ACE 011 | Day 8 | 0.83 | Standard Deviation 0.599 | g/dL |
| Change From Baseline in Hemoglobin | 0.5 mg/kg ACE 011 | Day 8 | 0.80 | Standard Deviation 0.844 | g/dL |
| Change From Baseline in Hemoglobin | Placebo | Day 29 | 0.50 | Standard Deviation 0.607 | g/dL |
| Change From Baseline in Hemoglobin | 0.1 mg/kg ACE 011 | Day 29 | -0.91 | Standard Deviation 1.844 | g/dL |
| Change From Baseline in Hemoglobin | 0.3 mg/kg ACE 011 | Day 29 | 0.66 | Standard Deviation 0.457 | g/dL |
| Change From Baseline in Hemoglobin | 0.5 mg/kg ACE 011 | Day 29 | 0.96 | Standard Deviation 1.648 | g/dL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00747123/results